Wilmar International Shares Plunge on Indonesia Export Probe AI Boom Intensifies Optical Tech Supply Constraints as Huawei Stages Chip Comeback China Urges APEC Cooperation as Commerce Minister Skips Opening Meeting Due to Urgent Business Argus Upgrades BP to Buy Following Strong Earnings Beat Financial Services Roundup Market Talks Highlight Experian SoFi and Others Major League Pickleball Returns Los Angeles Mad Drops Ben Johns Lead Season Opener Maplebear Inc CART Q1 2026 Earnings Earnings Miss Expectations Amid Quiet Revenue Disclosures GOODO Q1 2026 Earnings Preferred Stock Rises as EPS Surges Past Estimates PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter MBX Q1 2026 Earnings Narrower Than Expected Loss as Clinical Progress Continues EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Cost Discipline Drives Profitability Halozyme Therapeutics HALO Holds Above Key Support as Selling Pressure Eases Douglas Emmett DEI Holds Steady Near Resistance as Office Real Estate Sentiment Stabilizes TD SYNNEX SNX Holds Gains Near Resistance After Steady Rally Professional Diversity Network Inc IPDN Faces Selling Pressure Nears Key Support Level Ultragenyx RARE Dips 135 as Stock Tests Key Support Zone Near 2222 Septerna Inc SEPN Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response Dave Busters Entertainment Inc PLAY Q1 2026 Earnings Massive EPS Miss Masks Surprising Stock Rally Texas Capital Bancshares Series B TCBIO Q1 2026 Earnings EPS Exceeds Estimates as Preferred Stock Holds Steady BKD Q1 2026 Earnings EPS Misses Estimates Stock Declines Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges PL Asset Management CIO Sees Opportunity in Indian Equities Amid Sentiment Weakness CMS Energy Q1 2026 Earnings Solid EPS Beat Driven by Regulatory Tailwinds and Operational Efficiency Black Diamond Therapeutics BDTX Shares Tumble Nearly 35 on Clinical Setback